Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Department of Gastroenterology, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
J Crohns Colitis. 2018 Nov 15;12(11):1288-1294. doi: 10.1093/ecco-jcc/jjy092.
The current goal of treatment for ulcerative colitis [UC] is endoscopic and ultimately histological mucosal healing. However, there is no consensus on the definition of histological mucosal healing. We evaluated histological risk factors for clinical relapse in UC patients with endoscopically normal mucosa to focus on the importance of histological evaluation.
Patients with UC who underwent colonoscopy confirming Mayo endoscopic subscore [MES] ≤ 1 with biopsies were enrolled into this retrospective cohort. Three expert pathologists evaluated the presence or absence of chronic inflammatory cell infiltrate, breaches in the surface epithelium, crypt abscesses, mucin depletion, crypt architectural irregularities and basal plasmacytosis. Clinical relapse was defined as partial Mayo score ≥ 3 or modification of induction treatment. Prediction models of clinical relapse were generated, especially in patients with MES 0.
A total of 194 UC patients were enrolled. Histological abnormalities existed more frequently in patients with MES 1 than those with MES 0, while the vast majority of patients still possessed at least one abnormality. There was no significant difference in time to relapse between MES 0 and 1. Crypt architectural irregularities and mucin depletion were associated with time to relapse in patients with MES ≤ 1. In patients with MES 0, the presence of mucin depletion was the only factor significantly and independently associated with the risk of relapse (hazard ratio, 2.18 [1.16-5.82]; p = 0.03).
Mucin depletion was shown to be a histological risk factor for clinical relapse in UC patients with MES 0.
目前溃疡性结肠炎[UC]的治疗目标是内镜下和最终的组织学黏膜愈合。然而,对于组织学黏膜愈合的定义尚未达成共识。我们评估了内镜下黏膜正常的 UC 患者发生临床复发的组织学危险因素,以关注组织学评估的重要性。
本回顾性队列研究纳入了接受结肠镜检查并证实 Mayo 内镜评分[MES]≤1 且有活检的 UC 患者。三位专家病理学家评估了慢性炎症细胞浸润、表面上皮破裂、隐窝脓肿、粘蛋白耗竭、隐窝结构不规则和基底浆细胞浸润的存在或缺失。临床复发定义为部分 Mayo 评分≥3 或诱导治疗的改变。生成了临床复发的预测模型,特别是在 MES 0 的患者中。
共纳入 194 例 UC 患者。MES 1 的患者组织学异常更为常见,而 MES 0 的患者则更为常见,但绝大多数患者仍存在至少一种异常。MES 0 和 1 的患者复发时间无显著差异。在 MES≤1 的患者中,隐窝结构不规则和粘蛋白耗竭与复发时间相关。在 MES 0 的患者中,粘蛋白耗竭的存在是与复发风险显著相关的唯一因素(危险比,2.18[1.16-5.82];p=0.03)。
在 MES 0 的 UC 患者中,粘蛋白耗竭是临床复发的组织学危险因素。